Tendonitis Treatment Market Size & Share 2024 – 2032

Tendonitis Treatment Market Size

Tendonitis Treatment Market size was valued at around USD 214.6 billion in 2023 and is anticipated to register a CAGR of 3.8% between 2024 and 2032. Tendonitis is a condition characterized by inflammation or irritation of a tendon. Tendons are fibrous tissues that connect muscles to bones, and when they become inflamed, it can result in pain, swelling, and discomfort in the affected area. Tendonitis often occurs due to overuse, repetitive motion, or strain on a particular tendon.

Robust market growth can be attributed to various factors, including the rising prevalence of sedentary, lifestyles, the continual growth of healthcare expenditure, and ongoing technological advancements in tendonitis treatment. Additionally, a growing trend is observed towards an increasing preference for knee braces, which is estimated to reach USD 2.8 billion in 2032, among other contributing factors.
 

Furthermore, anticipated market expansion is attributed to multiple factors, including the rising incidence of cardiovascular, elderly population, sports and physical activities contributes to a higher incidence of tendonitis, especially among athletes. For instance, in 2022, according to National Safety Council Sports and recreational injuries increased by 12%.
 

Tendonitis Treatment Market Trends

Market expansion is anticipated to be propelled by the introduction of innovative tendonitis treatment techniques. Recently introduced advanced imaging technologies such as ultrasound and MRI, specialized surgical instruments has improved the diagnosis and monitoring of tendonitis. Shockwave therapy, 3D printing for orthopedic implants, robot-assisted surgery, functional electrical stimulation, and all these contribute to more precise diagnostics, individualized treatment plans, and improved patient outcomes in the management of tendonitis, thereby promoting demand for tendonitis treatment.
 

• The shift from static to dynamic variable monitoring and the advancement of minimally invasive monitoring approaches are projected to foster market growth in the forecast period.
   
• For instance, in September 2021, Stryker's Trauma and Extremities division successfully launched the Citrelock Tendon Trauma Fixation Device System. This innovative system presented surgeons with a distinctive design, incorporating a tendon thread utilizing the proprietary resorbable technology and benefited company by expanding its product portfolio in the orthopedic surgery domain.
   
• Furthermore, the escalating preference for tendon repair market has also stimulated increased focus on research and development, aiming to improve the overall experience for patients, enhance treatment outcomes, and advance the efficiency of tendonitis therapy.
   

Tendonitis Treatment Market Analysis

Based on treatment, the market is segmented into therapy, surgery, and medications. The therapy segmented is sub segmented into hot & cold therapy, physical therapy, and shockwave therapy. The therapy segment is estimated to account for USD 151.9 billion in 2023.
 

• Therapy plays a vital role in tendonitis treatment by providing targeted exercises and interventions to strengthen muscles, improve flexibility, alleviate pain, and promote healing, ultimately facilitating patients' recovery and restoring function in affected tendons.
   
• Furthermore, certain therapies, including hot & cold therapy, shockwave therapy, help to stimulate blood flow and promote tissue repair, facilitating the healing process of injured tendons.
   
• Moreover, therapies for tendonitis treatment offer significant advantages, including pain relief, promotion of healing, improved range of motion, and cost-effectiveness, contributing to better patient outcomes and satisfaction in the market.

Learn more about the key segments shaping this market

Download Free PDF

Based on application, the tendonitis treatment market is segmented into achilles tendonitis, supraspinatus tendonitis, tennis elbow, pitchers’ elbow, and jumper’s knee. The achilles tendonitis segment is expected reach a market size of USD 142.7 billion by 2032.
 

• Achilles tendonitis offers significant advantages to patients with effective relief without the need for surgery or invasive procedures.
   
• Moreover, the devices, such as ankle braces or compression sleeves, protect the tendon during physical activity, preventing further irritation and allowing patients to maintain an active lifestyle while undergoing treatment.
   
• For instance, in July 2021, Ossur launched Rebound Post-Op Elbow Brace, a non-invasive, lightweight adjustable brace designed to optimize the fitting experience for clinicians and to improve the ease-of-use for patients recovering from severe elbow injury or surgical procedures. This product launch benefited the company by expanding its product portfolio.
   

Based on distribution channel the tendonitis treatment market is classified into hospital pharmacy, retail pharmacy, and online pharmacy. The hospital pharmacy segment accounted for a market size of USD of 86.2 billion in the year 2023.
 

• Hospital pharmacy have access to the latest research and innovations in tendonitis treatment, allowing them to stay at the forefront of evidence-based practice. This enables them to offer patients the most effective and up-to-date treatment options available.
   
• Additionally, hospital pharmacy is integrated into the healthcare system, allowing for seamless communication and coordination among healthcare providers to optimize patient care in tendonitis treatment. Thus, fostering the segmental growth.
   

Based on end-use the tendonitis treatment market is categorized into hospitals, speciality clinics, home care settings, and other end-users. The hospitals segment accounted for a business share of 44.3% in the forecast period.
 

• The hospital dominance in market share for tendonitis treatment can be attributed to healthcare capacity to effectively cater patients with various musculoskeletal conditions, including tendonitis, offering specialized care and treatment options tailored to individual needs.
   
• As per the National Library of Medicine, the success rate for surgical treatment of achilles tendinosis of insertion (TAI) surpasses 80% in most cases.
   
• Furthermore, the demand for precise tendonitis treatment is heightened in hospitals, especially given the necessity for conducting invasive surgical procedures.

North America tendonitis treatment market accounted for USD 87 billion revenue in 2023 and is predicted to witness substantial market growth over the analysis timeline.
 

• The significant market share is correlated with a sophisticated healthcare infrastructure, an increased prevalence of tendonitis cases, rapid technological advancements, the involvement of sports-related activities, such as high-impact exercises, contributes to the rising incidence of tendonitis.
   
• The trend of increasing age among the population and a rise in the prevalence of tendon-related injuries contribute to a higher demand for tendonitis treatment options.
   
• Individuals experiencing tendonitis symptoms, particularly athletes and older adults, seek various treatment modalities, including physical therapy and orthopedic interventions, to alleviate pain and improve mobility, leading to increased demand for tendonitis treatment solutions in the region.
   

Tendonitis Treatment Market Share

The tendonitis treatment industry is competitive in nature, with several large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel advanced products based on different technologies is among a key market strategy. Some of the leading industry players including Zimmer Biomet, Stryker, Ossur among others have a notable presence in the market.
 

Tendonitis Treatment Market Companies

Some of the eminent market participants operating in the tendonitis treatment industry include:

• Abbott Laboratories
• AstraZeneca
• Boehringer Ingelheim Pharmaceuticals, Inc.
• Bristol Myers Squibb Company
• Colfax Corporation
• GalxoSmithKline AG
• Johnson & Johnson
• Merck and Co., Inc.
• Ossur
• Pifzer Inc.
• Stryker Corporation
• Teva Pharmaceutical Industries Ltd.
• Tynor Orthotics Pvt. Ltd
• Zimmer Biomet Holdings, Inc.

Tendonitis Treatment Industry News:

• In January 2023, Zimmer Biomet Holdings, Inc. concluded a definitive agreement to acquire Embody, Inc. The acquisition included Embody's TAPESTRY bio integrative implant, specifically engineered for tendon healing, and TAPESTRY RC. This acquisition benefited company by strengthening its market position.
   
• In September 2022, Össur announced the successful launch of its revolutionary product, the POWER KNEE. This motor-powered "smart" prosthesis utilized advanced algorithms to detect human movement patterns, and this launched positively impacts the company's reputation, and offers potential for market expansion.
   

Tendonitis treatment market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Treatment

• Therapy
  • Hot & cold therapy
  • Physical therapy
  • Shockwave therapy 
• Surgical
• Medications
  • Oral
  • Topical

Market, By Application

• Achilles tendonitis
• Supraspinatus tendonitis
• Tennis elbow
• Pitcher’s elbow
• Jumper’s knee

Market, By Distribution Channel

• Hospital pharmacy
• Retail pharmacy
• Online pharmacy

Market, By End-use

• Hospitals
• Specialty clinics
• Home care settings
• Other end-users      

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East and Africa